FDA approves first T-cell therapy for a solid tumor
Using a tumor derived immunotherapy composed of a patient’s own disease-fighting white blood cells known as T-cells - specific type called tumor-infiltrating lymphocytes (TIL).
Krishna Bala, Ph.D.
I am an engineering leader with experience in technology, cybersecurity and healthcare.
- New York City
You may also enjoy
Microsoft Patches CVSS 10.0 Azure AI Foundry Flaw Enabling Unauthorized Privilege Escalation
Could a good old STRIDE-based threat modeling approach have caught this?
AI Speed is Security’s biggest adversary
Impossible to keep up with emergency reactive mode. Threatmodelling proactively is a critical need in a post-Mythos post-Astra world!
Context bombs and the evolving defense against autonomous AI agents
Context bombs and the evolving defense against autonomous AI agents
Anthropic’s Claude Mythos and the need for threat modeling
Claude Mythos makes the need for threatmodeling even more critical: Providing best practice guidelines to product teams on architectural patterns and anti-pa...